1 The George Institute for Global Health, Sydney, Australia.
2 Sydney Medical School, University of Sydney, Australia.
Int J Stroke. 2017 Aug;12(6):667-670. doi: 10.1177/1747493017701943. Epub 2017 Mar 24.
Background There is evidence to indicate that the lying flat head position increases cerebral blood flow and oxygenation in patients with acute ischemic stroke, but how these physiological effects translate into clinical outcomes is uncertain. The Head Position in Stroke Trial aims to determine the comparative effectiveness of lying flat (0°) compared to sitting up (≥30°) head positioning, initiated within 24 h of hospital admission for patients with acute stroke. Design An international, pragmatic, cluster-randomized, crossover, open, blinded outcome assessed clinical trial. Each hospital with an established acute stroke unit (cluster) site was required to recruit up to 140 consecutive cases of acute stroke (one phase of head positioning before immediately crossing over to the other phase of head positioning), including both acute ischemic stroke and intracerebral hemorrhage, in each randomized head position as a 'business as usual' policy. Objective To outline in detail the predetermined statistical analysis plan for the study. Methods All accumulated data will be reviewed and formally assessed. Information regarding baseline characteristics of patients, their process of care and management will be outlined, and for each item, statistically relevant descriptive elements will be described. For the trial outcomes, the most appropriate statistical comparisons are described. Results A statistical analysis plan was developed that is transparent, verifiable, and predetermined before completion of data collection. Conclusions We developed a predetermined statistical analysis plan for Head Position in Stroke Trial to avoid analysis bias arising from prior knowledge of the findings, in order to reliably quantify the benefits and harms of lying flat versus sitting up early after the onset of acute stroke. Trial registration ClinicalTrials.gov identifier NCT02162017; ANZCTR identifier ACTRN12614000483651.
有证据表明,急性缺血性脑卒中患者采取仰卧位可增加脑血流和氧合,但这些生理效应如何转化为临床结局尚不确定。“卒中患者头位试验”旨在确定急性脑卒中患者入院后 24 小时内采取仰卧位(0°)与坐立位(≥30°)头位的相对有效性。
这是一项国际性、实用性、集群随机、交叉、开放性、盲法结局评估临床试验。每个设有急性脑卒中单元的医院(集群)需招募 140 例连续急性脑卒中患者(每个头位阶段各招募 70 例,先进行一个阶段的头位,然后立即交叉到另一个阶段),包括急性缺血性脑卒中及颅内出血,每个随机头位阶段均采用“常规治疗”策略。
详细介绍该研究的预定统计分析计划。
对所有累积数据进行审查和正式评估。描述患者的基线特征、治疗过程和管理信息,对于每个项目,将描述具有统计学意义的描述性元素。对于试验结局,将描述最合适的统计比较。
制定了一个透明、可核实和预先确定的统计分析计划,在完成数据收集之前就已制定。
我们为“卒中患者头位试验”制定了预定的统计分析计划,以避免因预先了解研究结果而产生分析偏倚,从而可靠地量化急性脑卒中发病后早期采取仰卧位与坐立位的益处和危害。
ClinicalTrials.gov 标识符:NCT02162017;ANZCTR 标识符:ACTRN12614000483651。